Arena Pharmaceuticals Total Assets 2006-2020 | ARNA

Arena Pharmaceuticals total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Arena Pharmaceuticals Annual Total Assets
(Millions of US $)
2019 $1,174
2018 $687
2017 $339
2016 $169
2015 $257
2014 $276
2013 $340
2012 $261
2011 $157
2010 $266
2009 $236
2008 $241
2007 $488
2006 $468
2005 $198
Arena Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2020-03-31 $1,090
2019-12-31 $1,174
2019-09-30 $1,242
2019-06-30 $1,285
2019-03-31 $1,330
2018-12-31 $687
2018-09-30 $610
2018-06-30 $638
2018-03-31 $685
2017-12-31 $339
2017-09-30 $348
2017-06-30 $189
2017-03-31 $140
2016-12-31 $169
2016-09-30 $210
2016-06-30 $218
2016-03-31 $241
2015-12-31 $257
2015-09-30 $286
2015-06-30 $329
2015-03-31 $362
2014-12-31 $276
2014-09-30 $297
2014-06-30 $335
2014-03-31 $368
2013-12-31 $340
2013-09-30 $295
2013-06-30 $278
2013-03-31 $237
2012-12-31 $261
2012-09-30 $264
2012-06-30 $259
2012-03-31 $188
2011-12-31 $157
2011-09-30 $185
2011-06-30 $210
2011-03-31 $233
2010-12-31 $266
2010-09-30 $293
2010-06-30 $235
2010-03-31 $227
2009-12-31 $236
2009-09-30 $267
2009-06-30 $164
2009-03-31 $196
2008-12-31 $241
2008-09-30 $340
2008-06-30 $407
2008-03-31 $465
2007-12-31 $488
2007-09-30 $425
2007-06-30 $452
2007-03-31 $437
2006-12-31 $468
2006-09-30 $331
2006-06-30 $347
2006-03-31 $365
2005-12-31 $198
2005-09-30 $218
2005-06-30 $230
2005-03-31 $234
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.202B $0.806B
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $142.669B 15.50
Bristol Myers Squibb (BMY) United States $134.562B 11.24
CSL (CSLLY) Australia $91.768B 0.00
Gilead Sciences (GILD) United States $88.910B 12.79
Vertex Pharmaceuticals (VRTX) United States $71.813B 40.07
Regeneron Pharmaceuticals (REGN) United States $71.339B 27.50
Illumina (ILMN) United States $57.871B 59.47
Biogen (BIIB) United States $43.707B 7.48
Moderna (MRNA) United States $29.126B 0.00
Seattle Genetics (SGEN) United States $28.722B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.736B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.061B 9.61
Genmab (GMAB) Denmark $23.061B 18.97
Genmab (GNMSF) Denmark $21.833B 64.82
Incyte (INCY) United States $21.726B 0.00
BioMarin Pharmaceutical (BMRN) United States $21.670B 157.67
BeiGene (BGNE) Cayman Islands $19.895B 0.00
BioNTech SE (BNTX) Germany $18.818B 0.00
Alnylam Pharmaceuticals (ALNY) United States $17.622B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.565B 70.47
Exact Sciences (EXAS) United States $13.957B 0.00
Galapagos (GLPG) Belgium $12.394B 36.46
Sarepta Therapeutics (SRPT) United States $12.223B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.788B 29.01
ARGENX SE-ADR (ARGX) Netherlands $10.887B 0.00
QIAGEN (QGEN) Netherlands $10.816B 31.45
Bio-Techne Corp (TECH) United States $10.584B 73.25
Immunomedics (IMMU) United States $10.192B 0.00
Novavax (NVAX) United States $9.109B 0.00
Repligen (RGEN) United States $8.219B 130.45
Guardant Health (GH) United States $7.994B 0.00
Ascendis Pharma (ASND) Denmark $7.808B 0.00
Exelixis (EXEL) United States $7.191B 25.22
ACADIA Pharmaceuticals (ACAD) United States $6.783B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.636B 205.59
Emergent Biosolutions (EBS) United States $6.490B 25.71
SWEDISH ORP BIO (BIOVF) Sweden $6.351B 15.80
Vir Biotechnology (VIR) United States $5.966B 0.00
Acceleron Pharma (XLRN) United States $5.715B 0.00
Mirati Therapeutics (MRTX) United States $5.414B 0.00
Adaptive Biotechnologies (ADPT) United States $5.160B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.100B 0.00
Reata Pharmaceuticals (RETA) United States $4.947B 0.00
Zai Lab (ZLAB) China $4.648B 0.00
MyoKardia (MYOK) United States $4.575B 0.00
MorphoSys AG (MOR) Germany $4.516B 35.03
NeoGenomics (NEO) United States $4.286B 1293.67
China Biologic Products (CBPO) China $4.196B 23.33
Global Blood Therapeutics (GBT) United States $4.190B 0.00
Blueprint Medicines (BPMC) United States $4.066B 0.00
Halozyme Therapeutics (HALO) United States $3.886B 0.00
Amicus Therapeutics (FOLD) United States $3.811B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.791B 0.00
Bluebird Bio (BLUE) United States $3.475B 0.00
Inovio Pharmaceuticals (INO) United States $3.212B 0.00
Alkermes (ALKS) Ireland $2.974B 62.33
Principia Biopharma (PRNB) United States $2.831B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.711B 0.00
Amarin (AMRN) Ireland $2.710B 0.00
Insmed (INSM) United States $2.702B 0.00
Sorrento Therapeutics (SRNE) United States $2.692B 0.00
Twist Bioscience (TWST) United States $2.553B 0.00
Fate Therapeutics (FATE) United States $2.534B 0.00
Denali Therapeutics (DNLI) United States $2.471B 0.00
PHARMA MAR SA (PHMMF) Spain $1.922B 0.00
Ligand Pharmaceuticals (LGND) United States $1.893B 64.09
UniQure (QURE) Netherlands $1.878B 0.00
Viela Bio (VIE) United States $1.839B 0.00
Mesoblast (MESO) Australia $1.805B 0.00
Editas Medicine (EDIT) United States $1.761B 0.00
I-Mab (IMAB) China $1.753B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.657B 0.00
Eidos Therapeutics (EIDX) United States $1.620B 0.00
Sangamo Therapeutics (SGMO) United States $1.612B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.567B 0.00
Zymeworks (ZYME) Canada $1.429B 0.00
Adverum Biotechnologies (ADVM) United States $1.416B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.374B 0.00
Revance Therapeutics (RVNC) United States $1.369B 0.00
Zealand Pharma (ZEAL) Denmark $1.366B 0.00
Mersana Therapeutics (MRSN) United States $1.361B 0.00
Intra-Cellular Therapies (ITCI) United States $1.354B 0.00
NGM Biopharmaceuticals (NGM) United States $1.310B 0.00
Cytokineticsorporated (CYTK) United States $1.310B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.269B 8.86
REGENXBIO (RGNX) United States $1.257B 0.00
Epizyme (EPZM) United States $1.243B 0.00
Arvinas (ARVN) United States $1.193B 0.00
Alector (ALEC) United States $1.187B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.161B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.157B 0.00
Akcea Therapeutics (AKCA) United States $1.131B 0.00
Alcobra (ARCT) United States $1.126B 0.00
Compugen (CGEN) Israel $1.100B 0.00
NantKwest (NK) United States $1.090B 0.00
VBI Vaccines (VBIV) United States $1.013B 0.00
Intellia Therapeutics (NTLA) United States $1.007B 0.00
Beam Therapeutics (BEAM) United States $0.999B 0.00
Retrophin (RTRX) United States $0.987B 0.00
Arcus Biosciences (RCUS) United States $0.967B 0.00
Heska (HSKA) United States $0.939B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.932B 40.04
Athenex (ATNX) United States $0.917B 0.00
Myriad Genetics (MYGN) United States $0.915B 47.19
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.873B 0.00
Dynavax Technologies (DVAX) United States $0.831B 0.00
Cara Therapeutics (CARA) United States $0.806B 0.00
Intrexon (PGEN) United States $0.796B 0.00
Vericel (VCEL) United States $0.759B 140.17
Pharming Group (PHGUF) Netherlands $0.739B 16.86
Cellectis S.A (CLLS) France $0.733B 0.00
Codexis (CDXS) United States $0.723B 0.00
Castle Biosciences (CSTL) United States $0.712B 0.00
Morphic Holding (MORF) United States $0.705B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.684B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.661B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
MiMedx (MDXG) United States $0.629B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Kadmon Holdings (KDMN) United States $0.592B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.591B 5.06
Agenus (AGEN) United States $0.578B 0.00
Cue Biopharma (CUE) United States $0.546B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.537B 0.00
Athersys (ATHX) United States $0.522B 0.00
IBio (IBIO) United States $0.520B 0.00
Kala Pharmaceuticals (KALA) United States $0.509B 0.00
Prothena (PRTA) Ireland $0.501B 0.00
Syros Pharmaceuticals (SYRS) United States $0.496B 0.00
AnaptysBio (ANAB) United States $0.493B 0.00
MeiraGTx Holdings (MGTX) United States $0.490B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.489B 0.00
Clovis Oncology (CLVS) United States $0.481B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 0.00
Innate Pharma S.A (IPHA) France $0.475B 0.00
Anika Therapeutics (ANIK) United States $0.471B 20.58
UROGEN PHARMA (URGN) United States $0.464B 0.00
Cel-Sci (CVM) United States $0.453B 0.00
Protagonist Therapeutics (PTGX) United States $0.443B 0.00
BioDelivery Sciences (BDSI) United States $0.427B 22.42
Puma Biotechnology (PBYI) United States $0.425B 0.00
Avid Bioservices (CDMO) United States $0.424B 0.00
Prometic Life Sciences (LMNL) Canada $0.416B 0.00
Kamada (KMDA) Israel $0.394B 16.41
Xenon Pharmaceuticals (XENE) Canada $0.393B 0.00
PDL BioPharma (PDLI) United States $0.392B 344.00
Aquinox Pharmaceuticals (NLTX) United States $0.392B 0.00
Merus (MRUS) Netherlands $0.391B 0.00
ANI Pharmaceuticals (ANIP) United States $0.380B 7.40
Scholar Rock Holding (SRRK) United States $0.379B 0.00
Albireo Pharma (ALBO) United States $0.371B 0.00
MannKind (MNKD) United States $0.354B 0.00
Geron (GERN) United States $0.352B 0.00
Precision BioSciences (DTIL) United States $0.350B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.343B 0.00
CytomX Therapeutics (CTMX) United States $0.334B 0.00
WAVE Life Sciences (WVE) Singapore $0.321B 0.00
Seres Therapeutics (MCRB) United States $0.320B 0.00
ChromaDex (CDXC) United States $0.314B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.305B 0.00
Trevena (TRVN) United States $0.300B 0.00
Menlo Therapeutics (MNLO) United States $0.297B 0.00
OSMOTICA PHARM (OSMT) United States $0.293B 0.00
ADMA Biologics Inc (ADMA) United States $0.291B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.289B 0.00
Affimed (AFMD) Germany $0.285B 0.00
Starpharma Holdings (SPHRY) Australia $0.276B 0.00
Spero Therapeutics (SPRO) United States $0.275B 0.00
Cellular Biomedicine (CBMG) United States $0.263B 0.00
NextCure (NXTC) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.260B 0.00
Pluristem Therapeutics (PSTI) Israel $0.259B 0.00
Arbutus Biopharma (ABUS) United States $0.259B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
Celldex Therapeutics (CLDX) United States $0.252B 0.00
Pfenex (PFNX) United States $0.251B 0.00
Dyadic (DYAI) United States $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.244B 0.00
Verastem (VSTM) United States $0.241B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.235B 0.00
Fortress Biotech (FBIO) United States $0.232B 0.00
Selecta Biosciences (SELB) United States $0.229B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Five Prime Therapeutics (FPRX) United States $0.222B 0.00
IVERIC Bio (ISEE) United States $0.221B 0.00
Strongbridge Biopharma (SBBP) United States $0.220B 0.00
Aduro Biotech (ADRO) United States $0.216B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.210B 9.80
Exicure (XCUR) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.200B 0.00
Sutro Biopharma (STRO) United States $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Aptinyx (APTX) United States $0.189B 0.00
Theratechnologies (THTX) Canada $0.188B 0.00
XOMA (XOMA) United States $0.187B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Aytu Bioscience (AYTU) United States $0.172B 0.00
Cerecor (CERC) United States $0.171B 0.00
VTv Therapeutics (VTVT) United States $0.169B 0.00
Bellus Health (BLU) Canada $0.164B 0.00
Liquidia Technologies (LQDA) United States $0.161B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.151B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Kindred Biosciences (KIN) United States $0.140B 0.00
Cyclerion Therapeutics (CYCN) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.138B 0.00
Palatin Technologies (PTN) United States $0.131B 3.37
Lineage Cell Therapeutics (LCTX) United States $0.127B 0.00
Checkpoint Therapeutics (CKPT) United States $0.126B 0.00
Biofrontera AG (BFRA) Germany $0.126B 0.00
Cardiff Oncology (CRDF) United States $0.124B 0.00
Gritstone Oncology (GRTS) United States $0.123B 0.00
Oncobiologics (OTLK) United States $0.121B 0.00
Cocrystal Pharma (COCP) United States $0.120B 0.00
Orgenesis (ORGS) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Windtree Therapeutics (WINT) United States $0.118B 0.00
Protalix BioTherapeutics (PLX) Israel $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.116B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.111B 0.00
Vaccinex (VCNX) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
ARAVIVE, INC (ARAV) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.093B 0.00
Proteostasis Therapeutics (PTI) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.091B 0.00
Unum Therapeutics (UMRX) United States $0.089B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
Ecology Coatings (ABVC) United States $0.079B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Stealth BioTherapeutics (MITO) United States $0.073B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.069B 0.00
AnPac Bio-Medical Science (ANPC) China $0.068B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Bionano Genomics (BNGO) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.064B 0.00
Soligenix (SNGX) United States $0.063B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
Happiness Biotech Group (HAPP) China $0.061B 0.00
Signal Genetics (MGEN) United States $0.061B 0.00
IMMURON (IMRN) Australia $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Prana Biotechnology (ATHE) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Curis (CRIS) United States $0.048B 0.00
AmpliPhi Biosciences (ARMP) United States $0.042B 0.00
Celsion (CLSN) United States $0.042B 0.00
Spherix (AIKI) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Genetic Technologies (GENE) Australia $0.035B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Chanticleer Holdings (SONN) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.033B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.031B 0.00
Forte Biosciences (FBRX) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.030B 0.00
Evogene (EVGN) Israel $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
Novogen (KZIA) Australia $0.028B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00